Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/27/2003CA2445513A1 Benzimidazole derivatives
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/27/2003CA2425784A1 Diagnostic markers for ischemia
03/27/2003CA2423945A1 Restrainers of airway mucus secretion
03/26/2003WO2002026732A1 Benzodiazepine derivative
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295893A1 SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1
03/26/2003EP1295883A1 Medicines for the prevention and treatment of neurodegenerative diseases
03/26/2003EP1295881A1 Compositions for treating or preventing malaria and method of treating malaria
03/26/2003EP1295879A1 Medicinal compositions containing propenone derivatives
03/26/2003EP1295875A1 Heterocyclic compounds
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295872A1 Drug composition antagonistic to both pgd 2?/txa 2? receptors
03/26/2003EP1295871A1 Vitamin d derivatives
03/26/2003EP1295869A2 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
03/26/2003EP1295611A1 Oligonucleotide-transferring preparations
03/26/2003EP1295609A1 Drugs containing combined active ingredients
03/26/2003EP1295608A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
03/26/2003EP1295607A1 Antitumor effect potentiators
03/26/2003EP1295602A1 Oxygen-containing ophthalmic composition
03/26/2003EP1295601A1 Pharmaceutical composition based on a non-steroid anti-inflammatory agent
03/26/2003EP1295600A2 Medicament based on gestagens for dermal application
03/26/2003EP1295599A1 Method for the treatment of prevention of atopic dermatitis
03/26/2003EP1295598A1 Pharmaceutical composition containing two active ingredients for smoking cessation
03/26/2003EP1295597A1 Antitumour compositions containing taxan derivatives
03/26/2003EP1295538A2 Encapsulated locust bean fibre with improved properties, process for making it and use thereof
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
03/26/2003EP1294883A2 Human extracellular matrix (ecm)-related tumor marker
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294854A2 Cell line for the expression of an alpha2-delta2 calcium channel subunit
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294742A2 Urokinase inhibitors
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294739A1 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity
03/26/2003EP1294737A1 Antisense modulation of c/ebp beta expression
03/26/2003EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003EP1294732A1 Ruthenium (ii) compounds for use in the therapy of cancer
03/26/2003EP1294730A2 Novel cephalosporin compounds and process for preparing the same
03/26/2003EP1294729A1 2-aminoalkyl-thieno[2,3-d]pyrimidines
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294726A2 Improvements in and relating to chromophores
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294723A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294720A1 Non-nucleoside reverse transcriptase inhibitors
03/26/2003EP1294719A1 Melanocortin receptor ligands
03/26/2003EP1294718A2 6,5-fused bicyclic heterocycles
03/26/2003EP1294717A2 A thiazine oxazolidinone
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294715A1 Quinazoline ditosylate salt compounds
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294710A1 Indole derivatives useful for the treatment of cns disorders
03/26/2003EP1294709A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294705A1 Synthesis of cyclic compounds
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294697A1 1,2,3,5-tetrahydrobenzo[c]azepin-4-one derivatives having muscarinic antagonist activity
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294682A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
03/26/2003EP1294681A2 Fmoc-l-leucine and derivatives thereof as ppar- gamma agonists
03/26/2003EP1294679A1 Beta-amino acid nitrile derivatives
03/26/2003EP1294677A1 Benzophenones and sulfones as inhibitors of glycine uptake
03/26/2003EP1294446A2 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents
03/26/2003EP1294439A2 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system
03/26/2003EP1294422A1 Methods and systems for enhancing fluid flow through an obstructed vascular site
03/26/2003EP1294413A1 Sprayable wound care compositions
03/26/2003EP1294411A1 A novel treatment for cough
03/26/2003EP1294406A2 Modulation of chromosome function by chromatin remodeling agents
03/26/2003EP1294405A2 Prodrug compounds cleavable by thimet oligopeptidase
03/26/2003EP1294403A2 Tripeptide prodrug compounds
03/26/2003EP1294401A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
03/26/2003EP1294384A2 Use of lanthanum compounds for the treatment of bone diseases
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294382A1 7-hydroxyepiandrosterone having neuroprotective activity
03/26/2003EP1294381A1 Neuroprotective 7-beta-hydroxysteroids
03/26/2003EP1294380A1 A method for treating septic shock
03/26/2003EP1294379A1 A new use for deferiprone
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294377A2 Methods and compositions for the treatment of alcoholism and alcohol dependence
03/26/2003EP1294376A2 Medicament for combating respiratory depression
1 ... 5523 5524 5525 5526 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 ... 7860